|
MON1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.036110E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.501000E-01 |
| Normal-vs-Stage2 |
4.090000E-02 |
| Normal-vs-Stage3 |
7.384100E-04 |
| Normal-vs-Stage4 |
3.780900E-04 |
| Stage1-vs-Stage2 |
8.765500E-02 |
| Stage1-vs-Stage3 |
3.862300E-03 |
| Stage1-vs-Stage4 |
2.740000E-03 |
| Stage2-vs-Stage3 |
7.203400E-01 |
| Stage2-vs-Stage4 |
4.778000E-01 |
| Stage3-vs-Stage4 |
6.233600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.460100E-03 |
| Normal-vs-AfricanAmerican |
1.619190E-01 |
| Normal-vs-Asian |
2.271000E-01 |
| Caucasian-vs-AfricanAmerican |
9.525000E-01 |
| Caucasian-vs-Asian |
1.099370E-01 |
| AfricanAmerican-vs-Asian |
1.834240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.561970E-03 |
| Normal-vs-Female |
3.516200E-01 |
| Male-vs-Female |
1.783720E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.185580E-01 |
| Normal-vs-Age(41-60Yrs) |
2.959600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.620390E-03 |
| Normal-vs-Age(81-100Yrs) |
2.894100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.794000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.886200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.200800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.547740E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.398300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.929200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.027600E-02 |
| Normal-vs-Grade 2 |
5.320000E-02 |
| Normal-vs-Grade 3 |
2.433800E-02 |
| Normal-vs-Grade 4 |
2.027200E-04 |
| Grade 1-vs-Grade 2 |
3.482200E-02 |
| Grade 1-vs-Grade 3 |
2.054300E-02 |
| Grade 1-vs-Grade 4 |
5.180800E-04 |
| Grade 2-vs-Grade 3 |
7.169400E-01 |
| Grade 2-vs-Grade 4 |
2.200400E-02 |
| Grade 3-vs-Grade 4 |
6.753900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.290200E-01 |
| Normal-vs-ccB subtype |
8.477800E-02 |
| ccA subtype-vs-ccB subtype |
4.997800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.349700E-02 |
| Normal-vs-N1 |
6.416000E-01 |
| N0-vs-N1 |
8.450000E-01 |
|
|
